Skip to main content

Cancer and the heart: Novel insights of biology, diagnosis, and management

ICOS, in collaboration with the Thalheimer Center for Cardio-Oncology at the University of Pennsylvania, is delighted to announce that the journal of Cardio-Oncology is hosting a manuscript competition on the topic of "Cancer and the heart: Novel insights of biology, diagnosis and management."

A panel will judge the published articles and the following prize, sponsored by the Thalheimer Center for Cardio-Oncology at the University of PA, will be awarded based on impact and originality:

  • a fully waived APC on a second Cardio-Oncology manuscript within one year (the journal's standard peer review process would apply); 
  • ICOS dues paid for one year; 
  • free registration at GCOS 2023;
  • and prominent promotion of the winning article by ICOS and the journal.

The deadline for submissions is December 31, 2022. Submissions can be made through our editorial management system

If you have any questions, please contact the Editorial office.

New Content Item

 

  1. Cancer chemotherapy using anthracyclines is associated with cardiotoxicity (CTX), and left ventricular ejection fraction (LVEF) analysis is not sensitive to early cardiotoxic changes. Left ventricular global l...

    Authors: Diogo Pereira Santos Sampaio, João Batista Masson Silva, Daniela do Carmo Rassi, Aguinaldo F. Freitas Jr and Salvador Rassi
    Citation: Cardio-Oncology 2022 8:17